Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity
- 1 October 1991
- journal article
- Published by Elsevier in Kidney International
- Vol. 40 (4) , 742-747
- https://doi.org/10.1038/ki.1991.269
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- EFFECT OF PLATELET-ACTIVATING FACTOR ANTAGONIST ON CYCLOSPORINE NEPHROTOXICITYTransplantation, 1989
- Nephrotoxicity Induced by Cancer Chemotherapy With Special Emphasis on Cisplatin ToxicityAmerican Journal of Kidney Diseases, 1986
- Platelet-activating factor and the kidneyAmerican Journal of Physiology-Renal Physiology, 1986
- Reduced renal blood flow in early cisplatin-induced acute renal failure in the ratAmerican Journal of Physiology-Renal Physiology, 1985
- Cardiovascular and renal action of platelet-activating factor in anesthetized dogs.Hypertension, 1984
- Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells.Journal of Clinical Investigation, 1984
- Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneysKidney International, 1984
- Pathophysiology of altered glomerular function in aminoglycoside-treated ratsKidney International, 1981
- The Role of cis-Platinum in Solid-Tumor TherapyNew England Journal of Medicine, 1979
- Mechanisms of the defect in glomerular ultrafiltration associated with gentamicin administrationKidney International, 1977